Explore the evolution of India's MedTech sector in 2026, highlighted by consolidation, innovation, and ambitions for global ...

Walking the myriad halls of the MEDICA convention gives a palpable sense of the innovation bursting at the seams of the medical device industry. From in vitro diagnostics (IVD) to novel technologies ...

When medical technology companies present new technologies to hospitals and health systems, the focus has historically been clinical outcomes. As health systems transition to value-based care, the ...

Edge is a Qualified Venture Fund of NJEDA's Innovation Evergreen Fund, enabling co-investment alongside state capital into New Jersey-based medtech companies. Earlier last week, Edge portfolio company ...

Though the medical technology industry’s revenues have reached an all-time high, that growth may not be sustainable due to slowed investment in innovation and a lack of collaboration between ...

India, Nov. 27 -- India stands at the cusp of a healthcare transformation - one which is powered by indigenous innovation, collaboration and commercial scalability. For decades, our medical technology ...

Healthcare technology is evolving fast: AI-powered diagnostics, health trackers and robotic-assisted surgeries are just a few of the innovations changing the game. With all this progress comes a major ...

Sanara MedTech (SMTI), together with Biomimetic Innovations, provided an update on progress related to their strategic alliance. In addition, Sanara reaffirmed its plans to introduce OsStic Synthetic ...

The state unveiled plans for its 12th strategic innovation center (SIC) July 21, a multilocation effort in Camden and Mullica Hill. Officials say this latest SIC will serve as an accelerator for South ...

Marcel Botha, CEO and founder of 10XBeta, a MedTech innovation firm and venture studio, joined MobiHealthNews to discuss the widespread and unintended consequences of tariffs imposed by the Trump ...

Poised for U.S. market launch in Q1 2027 following the achievement of recent milestones and OsStic’s granted patent in 2025 The FDA granted OsStic Breakthrough Device Designation in December 2023, ...

Poised for U.S. market launch in Q1 2027 following the achievement of recent milestones and OsStic’s granted patent in 2025 FORT WORTH, TX, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc.